Reduced uncertainty as a diagnostic benefit: An initial assessment of somatostatic receptor scintigraphy's value in detecting distant metastases of carcinoid liver tumours

Health Economics

Volumn 7, Issue 2, 1998, Pages 149-160

  Woodward, Robert S ^a   Schnitzler, Mark A ^a   Kvols, Larry K ^b  

^a WASHINGTON UNIVERSITY   (United States)

^b UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

Carcinoid liver tumour; Cost effectiveness; Octreotide; Risk aversion; Somatostatin receptor scintigraphy

Indexed keywords

INDIUM 111; SOMATOSTATIN RECEPTOR;

ARTICLE; CANCER STAGING; COST EFFECTIVENESS ANALYSIS; DATA BASE; ECONOMIC EVALUATION; HEALTH STATUS; LIVER RESECTION; LIVER TUMOR; METASTASIS; PRIORITY JOURNAL; RISK ASSESSMENT; SCINTIGRAPHY;

CARCINOID TUMOR; COST SAVINGS; COST-BENEFIT ANALYSIS; DECISION TREES; HEALTH STATUS; HUMANS; LIVER NEOPLASMS; MODELS, ECONOMETRIC; OCTREOTIDE; QUALITY-ADJUSTED LIFE YEARS; RISK FACTORS; TREATMENT OUTCOME;

EID: 0031977479     PISSN: 10579230     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1050(199803)7:2<149::AID-HEC321>3.0.CO;2-B     Document Type: Article

References (18)

1. Committee on Biological Effects of Ionizing Radiation, National Academy of Sciences/National Research Council. The effects of population of exposure to low levels of ionizing radiation. Washington, DC: National Academy Press, 1980.
2. Scott, L. Diagnostic imaging targeted for change. Modern Health Care 1993; 23: 34-41.
3. Fryback, D.F. and Thornbury, J.R. The efficacy of diagnostic imaging. Medical Decision Making 1991; 11: 88-94.
4. Littenberg, B. Technology assessment in medicine. Academic Medicine 1992; 67: 424-428.
5. Phelps, C.E. and Mushlin, A.I. Focusing technology assessment using medical decision theory. Medical Decision Making 1989; 8: 270-289.
6. United States National Cancer Institute. Gastrointestinal carcinoid tumor, file cn-101064, CancerNet April, 1994; URL: gopher://gopher nih.gov:70/11/clin/cancernet.
7. Marton, K.I., Larkin, J., Ward, J. et al. The role of the upper gastrointestinal series in the evaluation of abdominal pain. Clinical Research 1981; 29: 322A.
8. Vinik, A.I., Thompson, N., Eckhauser, F. and Moatiari, A.R. Clinical features of carcinoid syndrome and the use of somatostatin analogue in its management. Acta Oncologica 1989; 28: 389-402.
9. Woodward, R.S., Boyarsky, S. and Barnett, H. Discounting surgical benefits: enucleation versus resection of the prostate. Journal of Medical Systems 1983; 7: 481-493.
10. Harris, R.A. and Nease, R.F. Jr. The importance of patient preferences for comorbidities in cost-effectiveness analysis. Journal of Health Economics 1997; 16: 113-119.
11. von Neumann, J. and Morgenstern, O. Theory of games and economic behavior. Princeton, NJ: Princeton University Press, 1955.
12. Woodward, R.S. and Boxerman, S.B. The value of risk-reducing information. Journal of Medical Systems. 1994; 18: 111-116.
13. Kwekkeboom, D.J., Lamberts, S.W.J., Habbema, J.D.F. and Kremming, E.P. Cost-effectiveness analysis of somatostatin receptor scintigraphy. The Journal of Nuclear Medicine 199x; 37: 1-7.
14. Woodward, R.S. Efficient medical diagnoses: a model with two simulations. In: Shires D. and Wolfe H. (eds). Medinfo 77. New York: North Holland Press, 1977: 127-133.
15. Asch, D.A., Patton, J.P. and Hershey, J.C. Knowing for the sake of knowing: the value of prognostic information. Medical Decision Making. 1990; 10: 47-57.
16. Asch, D.A., Patton J.P. and Hershey, J.C. Prognostic information versus accuracy: once more with meaning. Medical Decision Making. 1991; 11: 45-47.
17. Mushlin, A.I., Mooney, C., Grow, V. and Phelps, C.E. The value of diagnostic information to patients with suspected multiple sclerosis. Archives of Neurology 1994; 51: 67-72.
18. Ewigman, B.G., Crane, J.P., Frigoletto, F.D., LeFevre, M.L., Bain, R.P. and McNellis, D. Effect of prenatal ultrasound screening on perinatal outcome. New England Journal of Medicine 1993; 16: 821-827.